Volume 57, Issue 8 pp. o723-o724

(+)-N-{4-[(1S,2S)-2-(Di­methyl­amino)-1-(1H-imidazol-1-yl)­propyl]­phenyl}-2-benzo­thia­zol­amine

Oswald M. Peeters

Oswald M. Peeters

Laboratorium voor Analytische Chemie en Medicinale Fysicochemie, Faculteit Farmaceutische Wetenschappen, Katholieke Universiteit Leuven, Van Evenstraat 4, B-3000 Leuven, Belgium

Search for more papers by this author
Norbert M. Blaton

Norbert M. Blaton

Laboratorium voor Analytische Chemie en Medicinale Fysicochemie, Faculteit Farmaceutische Wetenschappen, Katholieke Universiteit Leuven, Van Evenstraat 4, B-3000 Leuven, Belgium

Search for more papers by this author
Camiel J. De Ranter

Camiel J. De Ranter

Laboratorium voor Analytische Chemie en Medicinale Fysicochemie, Faculteit Farmaceutische Wetenschappen, Katholieke Universiteit Leuven, Van Evenstraat 4, B-3000 Leuven, Belgium

Search for more papers by this author
First published: 03 August 2004
Oswald M. Peeters, e-mail: [email protected]

Abstract

The metabolism of all-trans-retinoic acid is mediated by a cytochrome dependent P-450 system. The title compound, C21H23N5S, is an inhibitor of the P-450 system. Two planar rings connected via a central CH group form a dihedral angle of 80.2 (1)°; the planar systems connected through an NH group form a dihedral angle of 37.12 (8)°. The N—H⋯N hydrogen bonds link the mol­ecules of the title compound into infinite chains stretching along the c direction.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.